FDG and Beyond

Dirk de Ruysscher; Karin Haustermans; Daniela Thorwarth

doi:10.1007/978-3-662-49651-0_8

FDG and Beyond

Dirk de Ruysscher, Karin Haustermans, Daniela Thorwarth

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Abstract

Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.

Original language	English
Title of host publication	Molecular Radio-Oncology
Editors	Michael Baumann, Mechthild Krause, Nils Cordes
Publisher	Springer
Pages	163-173
Volume	198
ISBN (Electronic)	978-3-662-49651-0
ISBN (Print)	978-3-662-49649-7
DOIs	https://doi.org/10.1007/978-3-662-49651-0_8
Publication status	Published - 2016

Publication series

Series	Recent Results in Cancer Research

Access to Document

10.1007/978-3-662-49651-0_8

Cite this

@inbook{fef92583a14640e3aaf6185382f5cc84,

title = "FDG and Beyond",

abstract = "Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.",

author = "{de Ruysscher}, Dirk and Karin Haustermans and Daniela Thorwarth",

year = "2016",

doi = "10.1007/978-3-662-49651-0_8",

language = "English",

isbn = "978-3-662-49649-7",

volume = "198",

series = "Recent Results in Cancer Research",

publisher = "Springer",

pages = "163--173",

editor = "Michael Baumann and Mechthild Krause and Nils Cordes",

booktitle = "Molecular Radio-Oncology",

address = "United States",

}

TY - CHAP

T1 - FDG and Beyond

AU - de Ruysscher, Dirk

AU - Haustermans, Karin

AU - Thorwarth, Daniela

PY - 2016

Y1 - 2016

N2 - Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.

AB - Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.

U2 - 10.1007/978-3-662-49651-0_8

DO - 10.1007/978-3-662-49651-0_8

M3 - Chapter

C2 - 27318686

SN - 978-3-662-49649-7

VL - 198

T3 - Recent Results in Cancer Research

SP - 163

EP - 173

BT - Molecular Radio-Oncology

A2 - Baumann, Michael

A2 - Krause, Mechthild

A2 - Cordes, Nils

PB - Springer

ER -